Calcineurin inhibitors stimulate Kir4.1/Kir5.1 of the distal convoluted tubule to increase NaCl cotransporter.
Cell Biology
Hypertension
Nephrology
Potassium channels
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
10 04 2023
10 04 2023
Historique:
received:
04
10
2022
accepted:
21
02
2023
medline:
11
4
2023
pubmed:
24
2
2023
entrez:
23
2
2023
Statut:
epublish
Résumé
We examine whether calcineurin or protein phosphatase 2B (PP2B) regulates the basolateral inwardly rectifying potassium channel Kir4.1/Kir5.1 in the distal convoluted tubule (DCT). Application of tacrolimus (FK506) or cyclosporine A (CsA) increased whole-cell Kir4.1/Kir5.1-mediated K+ currents and hyperpolarized the DCT membrane. Moreover, FK506-induced stimulation of Kir4.1/Kir5.1 was absent in kidney tubule-specific 12 kDa FK506-binding protein-knockout mice (Ks-FKBP-12-KO). In contrast, CsA stimulated Kir4.1/Kir5.1 of the DCT in Ks-FKBP-12-KO mice, suggesting that FK506-induced stimulation of Kir4.1/Kir5.1 was due to inhibiting PP2B. Single-channel patch-clamp experiments demonstrated that FK506 or CsA stimulated the basolateral Kir4.1/Kir5.1 activity of the DCT, defined by NPo (a product of channel number and open probability). However, this effect was absent in the DCT treated with Src family protein tyrosine kinase (SFK) inhibitor or hydroxyl peroxide. Fluorescence imaging demonstrated that CsA treatment increased membrane staining intensity of Kir4.1 in the DCT of Kcnj10fl/fl mice. Moreover, CsA treatment had no obvious effect on phosphorylated NaCl cotransporter (pNCC) expression in Ks-Kir4.1-KO mice. Immunoblotting showed acute FK506 treatment increased pNCC expression in Kcnj10fl/fl mice, but this effect was attenuated in Ks-Kir4.1-KO mice. In vivo measurement of thiazide-induced renal Na+ excretion demonstrated that FK506 enhanced thiazide-induced natriuresis. This effect was absent in Ks-FKBP-12-KO mice and blunted in Ks-Kir4.1-KO mice. We conclude that inhibition of PP2B stimulates Kir4.1/Kir5.1 of the DCT and NCC and that PP2B inhibition-induced stimulation of NCC is partially achieved by stimulation of the basolateral Kir4.1/Kir5.1.
Identifiants
pubmed: 36821372
pii: 165987
doi: 10.1172/jci.insight.165987
pmc: PMC10132170
doi:
pii:
Substances chimiques
Solute Carrier Family 12, Member 3
0
Calcineurin Inhibitors
0
Sodium Chloride
451W47IQ8X
Tacrolimus
WM0HAQ4WNM
Tacrolimus Binding Protein 1A
EC 5.2.1.-
Thiazides
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDDK NIH HHS
ID : R56 DK054983
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK133220
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK115366
Pays : United States
Références
JCI Insight. 2017 Sep 21;2(18):
pubmed: 28931751
Lancet. 1983 Aug 13;2(8346):370-2
pubmed: 6135874
Am J Physiol Renal Physiol. 2016 May 1;310(10):F985-93
pubmed: 26887833
J Am Soc Nephrol. 2019 Feb;30(2):216-227
pubmed: 30559144
Am J Physiol Renal Physiol. 2009 Aug;297(2):F389-96
pubmed: 19474187
Am J Physiol Renal Physiol. 2021 May 1;320(5):F883-F896
pubmed: 33818128
Am J Physiol Renal Physiol. 2017 Mar 1;312(3):F489-F501
pubmed: 28003191
Kidney Int. 2021 Oct;100(4):850-869
pubmed: 34252449
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10361-6
pubmed: 21633011
Nature. 1989 Oct 26;341(6244):758-60
pubmed: 2477715
Am J Physiol Cell Physiol. 2008 Mar;294(3):C765-73
pubmed: 18184875
Cell. 1991 Aug 23;66(4):807-15
pubmed: 1715244
Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F903-F907
pubmed: 29923766
Kidney Int. 2018 Apr;93(4):893-902
pubmed: 29310825
J Biol Chem. 2014 May 9;289(19):13347-61
pubmed: 24668812
J Membr Biol. 1998 Feb 1;161(3):235-45
pubmed: 9493129
Am J Physiol Renal Physiol. 2020 Sep 1;319(3):F534-F540
pubmed: 32715757
Sci Signal. 2014 May 06;7(324):ra41
pubmed: 24803536
Clin Chem. 1993 Nov;39(11 Pt 1):2219-28
pubmed: 7693372
J Biol Chem. 1986 Jul 25;261(21):9890-5
pubmed: 2426255
J Biol Chem. 2013 Sep 6;288(36):26135-26146
pubmed: 23873931
Am J Physiol Renal Physiol. 2021 Jun 1;320(6):F1045-F1058
pubmed: 33900854
J Am Soc Nephrol. 1992 Feb;2(8):1279-84
pubmed: 1627752
J Am Soc Nephrol. 2016 May;27(5):1456-64
pubmed: 26432904
Am J Physiol Renal Physiol. 2013 Nov 1;305(9):F1277-87
pubmed: 23986512
Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F582-F586
pubmed: 30623727
J Am Soc Nephrol. 2016 Jan;27(1):107-19
pubmed: 25967121
Am J Physiol Renal Physiol. 2008 Jun;294(6):F1398-407
pubmed: 18367659
J Am Soc Nephrol. 2017 Jun;28(6):1814-1825
pubmed: 28052988
J Physiol. 2002 Jan 15;538(Pt 2):391-404
pubmed: 11790808
Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F254-F261
pubmed: 28356287
J Am Soc Nephrol. 2015 Nov;26(11):2678-90
pubmed: 25848073
J Biol Chem. 1996 Jan 12;271(2):695-701
pubmed: 8557675
Am J Physiol. 1995 Oct;269(4 Pt 2):F558-63
pubmed: 7485542
Nat Med. 2011 Oct 02;17(10):1304-9
pubmed: 21963515
Am J Physiol Cell Physiol. 2022 Aug 1;323(2):C277-C288
pubmed: 35759440
Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11864-9
pubmed: 25071208
Proc Natl Acad Sci U S A. 2012 May 15;109(20):7929-34
pubmed: 22550170
Kidney Int. 2017 Feb;91(2):402-411
pubmed: 28341239
Nat Genet. 1996 Jan;12(1):24-30
pubmed: 8528245
Cell Metab. 2011 Sep 7;14(3):352-64
pubmed: 21907141
J Gen Physiol. 2021 Aug 2;153(8):
pubmed: 34143184
Hypertension. 2008 Mar;51(3):588-96
pubmed: 18212265
Cell Metab. 2015 Jan 6;21(1):39-50
pubmed: 25565204
J Biol Chem. 2012 Nov 2;287(45):37673-90
pubmed: 22977235
Am J Physiol Renal Physiol. 2016 Jul 1;311(1):F12-5
pubmed: 27122539
Physiol Rev. 2020 Jan 1;100(1):321-356
pubmed: 31793845